Profile
Denis Angioletti is currently the Director at Lipidor AB since 2020 and the Chief Commercial Officer at Cerbios-Pharma SA since 2017.
Previously, he served as the Deputy Chief Executive Officer at Summit Pharmaceuticals Europe Ltd. from 2013 to 2017 and as the Marketing Manager at Archimica SRL from 1999 to 2007.
He obtained his undergraduate degree from the University of Milan.
Denis Angioletti active positions
| Companies | Position | Start |
|---|---|---|
| LIPIDOR AB | Director/Board Member | 2019-12-31 |
Cerbios-Pharma SA
Cerbios-Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures APIs, HPAPI, ADCs & biological probiotics for international human and animal market | Corporate Officer/Principal | 2017-05-31 |
Former positions of Denis Angioletti
| Companies | Position | End |
|---|---|---|
Summit Pharmaceuticals Europe Ltd.
Summit Pharmaceuticals Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Markets pharmaceutical intermediates and raw materials | Corporate Officer/Principal | 2016-12-31 |
Archimica SRL
Archimica SRL Pharmaceuticals: MajorHealth Technology Manufactures active pharmaceutical ingredients | Sales & Marketing | 2006-12-31 |
Training of Denis Angioletti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Archimica SRL
Archimica SRL Pharmaceuticals: MajorHealth Technology Manufactures active pharmaceutical ingredients | Health Technology |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipidor AB
Lipidor AB Miscellaneous Commercial ServicesCommercial Services Develops and commercializes lipid-based topical medication products | Commercial Services |
Summit Pharmaceuticals Europe Ltd.
Summit Pharmaceuticals Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Markets pharmaceutical intermediates and raw materials | Commercial Services |
Cerbios-Pharma SA
Cerbios-Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures APIs, HPAPI, ADCs & biological probiotics for international human and animal market | Health Technology |
- Stock Market
- Insiders
- Denis Angioletti
















